Amerisourcebergen Corp: (NYSE: ABC)

$54.46

-0.19 (-0.35%)

Volume 2,464,084

May 22 04:00 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		54.37 - 55.11
	
		52wk Low - High
		35.98 - 56.91
	
		Previous Close
		54.65
	
		Avg. Volume
		2,602,832
	
		Industry
		RETAIL-DRUG STR
	
		Market Cap
		12.58 B
	
		Div - Yield
		0.84 - 1.54
	
		Beta
		0.74
	
		PE (Forward)
		17.98
	
		Current Year Est.
		3.04
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		42 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 04/26/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            17.98
                        
                            PEG Ratio
                            1.54
                        
                            Current Year Est.
                            3.04
                        
                            Current Quarter Estimate
                            0.75
                        
                            Most Accurate Estimate
                            0.75
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            07-25-2013
                        
                            EPS Last Year
                            2.95
                        
                            Expected Earnings Growth
                            11.67%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living facilities, reimbursement and pharmaceutical consulting services, and physician education.   
Full ABC Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
ABC Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (09/2013)	Next Year (09/2014)
Average Estimate	0.75	0.73	3.04	3.65
Number of Estimates	8	7	1	9
Low Estimate	0.71	0.69	3.04	3.55
High Estimate	0.80	0.80	3.04	NA
Year Ago EPS	0.72	0.69	2.83	3.04
EPS Growth	4.17%	6.00%	7.42%	20.10%

More ABC Estimates

Average Earnings Estimates for ABC

EPS Growth for ABC

Industry Analysis

Name	Symbol	Previous Close
AMERISOURCEBRGN	ABC	54.65
CHINA NEPSTAR	NPD	1.71
GNC HOLDINGS	GNC	45.78
HERBALIFE LTD	HLF	50.54
RITE AID CORP	RAD	2.89
CARDINAL HEALTH	CAH	47.96
CVS CAREMARK CP	CVS	59.51
MCKESSON CORP	MCK	118.41
PHARMERICA CORP	PMC	14.19
BIOSCRIP INC	BIOS	13.68

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

COMPARE TICKER vs. Its Peers

Zacks Commentary

The Zacks Analyst Blog Highlights: Walgreen, AmerisourceBergen, CVS Caremark, Cardinal Health and R.R. Donnelley & Sons

May 21, 2013

Green Light for WAG and ABC Deal

May 20, 2013

Walgreens Reaches New 52-Week High

May 16, 2013

Walgreens-CVS Extend Pharmacy Deal

May 14, 2013

AmerisourceBergen Misses Estimates

Apr 25, 2013

Earnings Preview: AmerisourceBergen

Apr 24, 2013

Still Neutral on Walgreens

Apr 18, 2013

The Zacks Analyst Blog Highlights: AmerisourceBergen, Walgreens, Cardinal Health, CVS Caremark and Duke Energy

Apr 04, 2013

More ABC Zacks Commentary

Financials

EPS TTM	2.95
Sales	79,490
Net Income	559
Price/Earnings	18.52
Price/Book	5.36
Price/Cash Flow	15.75
Price/Sales	0.15

More ABC Financials

News

AmerisourceBergen Has Returned 39.0% Since SmarTrend Recommendation (ABC) - Comtex Smartrend(R)

May 22, 2013

AmerisourceBergen (ABC) Approaches New Downside Target of $54.40 - Financial News Network Online - Pivot Alerts

May 21, 2013

AmerisourceBergen Garners Regulatory Approval of Walgreens and Alliance Boots Equity Investment - Close-Up Media

May 21, 2013

AmerisourceBergen Reports Approval of Walgreens and Alliance Boots Equity Stake - Close-Up Media

May 21, 2013

AmerisourceBergen Secures Regulatory Approval of Walgreens and Alliance Boots Equity Investment - Close-Up Media

May 21, 2013

AmerisourceBergen Wins Regulatory Approval of Walgreens and Alliance Boots Equity Investment - Close-Up Media

May 21, 2013

The Zacks Analyst Blog Highlights: Walgreen, AmerisourceBergen, CVS Caremark, Cardinal Health and R.R. Donnelley & Sons - Pr Newswire

May 21, 2013

Walgreens and Alliance Boots Acheive Regulatory Clearance to Make Equity Investment in AmerisourceBergen - Close-Up Media

May 21, 2013

See All News Stories on ABC

Broker Recommendations

Current ABR	2.25
ABR (Last Week)	2.25
# of recs in ABR	8
Average Target Price	56.79
Industry Rank by ABR	42 out of 265
Rank in Industry	5 out of 11

More ABC Broker Recommendations

Day Low - High	54.37 - 55.11
52wk Low - High	35.98 - 56.91
Previous Close	54.65
Avg. Volume	2,602,832
Industry	RETAIL-DRUG STR
Market Cap	12.58 B
Div - Yield	0.84 - 1.54
Beta	0.74
PE (Forward)	17.98
Current Year Est.	3.04
Quarterly Earnings ESP	0.00%

PE (Forward)	17.98
PEG Ratio	1.54
Current Year Est.	3.04
Current Quarter Estimate	0.75
Most Accurate Estimate	0.75
Earnings ESP	0.00%
Next Earnings Report Date	07-25-2013
EPS Last Year	2.95
Expected Earnings Growth	11.67%

Username: Password:

Remember me [?]

Amerisourcebergen Corp: (NYSE: ABC)

$54.46

-0.19 (-0.35%)

Volume 2,464,084

May 22 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

Zacks Commentary

Financials

News

Broker Recommendations